Improved transaminase and application thereof in preparation of (R)-3-aminobutanol

A transaminase and transaminase technology, applied in the application, transferase, enzyme and other directions, can solve the problems of inability to meet the needs of industrial production, increase operation and cost, increase the discharge of industrial three wastes, etc., to achieve good industrial application prospects and reduce production. Cost, product chiral purity and high yield

Active Publication Date: 2017-05-31
SYNCOZYMES SHANGHAI
View PDF9 Cites 15 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Patent CN 104131048A discloses a method for asymmetrically catalyzing 4-hydroxy-2-butanone to synthesize (R)-3-aminobutanol using wild-type D-transaminase, but the highest reaction substrate concentration is only 300mM (26.4g/ L), can't meet industrialized production dem

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Improved transaminase and application thereof in preparation of (R)-3-aminobutanol
  • Improved transaminase and application thereof in preparation of (R)-3-aminobutanol
  • Improved transaminase and application thereof in preparation of (R)-3-aminobutanol

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0032] Example 1 Construction of transaminase mutant library

[0033] The sequence of the whole gene synthesis is shown in SEQ ID No.1, and two restriction sites, NdeI and HindIII, were selected and inserted into the pET24a expression vector, and the obtained recombinant expression vector was named pET24a-AtAT. To construct the mutant library, we designed the following 6 primers, see Table 1 for details:

[0034] Table 1 PCR primer table

[0035]

[0036] Use pET24a-AtAT as a template and use the above primers to carry out PCR amplification. The PCR system is: 10×PCR buffer is 5uL, 2.5mM dNTP is 4uL, pfu DNA Polymerse is 0.5uL, pET24a-AtAT template is 0.5uL (including DNA template 0.2 ug), ddH 2O is 36uL, and the AtAT-up upstream primer (SEQ ID No.9) and H55-down downstream primer (SEQ ID No.12), H55-up upstream primer (SEQ ID No.11) and S215- 2uL (10umol / L) of the down downstream primer (SEQ ID No.14), the S215-up upstream primer (SEQ ID No.13) and the AtAT-down downstr...

Embodiment 2

[0037] Example 2 Expression and Screening of Transaminase Mutants

[0038] Inoculate 100uL of bacterial liquid from each well of the overnight-cultivated mutant library into a new 96-well plate, which contains 1mL of fresh LB+kanamycin medium in each well, and culture on a shaker at 37°C until OD 600 When the value reaches 0.8-1.0, add IPTG to a final concentration of 1.0 mM, induce culture at 25°C for about 20 hours, discard the supernatant by centrifugation, and collect the bacteria. Add 400uL reaction solution to each well, which includes: 20g / L substrate 4-hydroxyl-2-butanone, 60g / L isopropylamine, 1mM coenzyme PLP, 100mM potassium phosphate buffer (pH=8.0), at 30 After 24 hours of shaking reaction at ℃, add 10M NaOH to each well to adjust the pH>13, add an equal volume of ethyl acetate for extraction, and after centrifugation, absorb the organic layer for GC analysis to detect the enzyme activity of the mutant. GC conditions: Agilent 7820A gas chromatograph; RESTEK (30...

Embodiment 3

[0039] Example 3 Expression of AtATmut transaminase and preparation of enzyme powder

[0040] Transfer the glycerol-preserved strain BL21(DE3) / pET24a-AtATmut to 5 mL of LB test tube medium containing kanamycin for activation culture (cultivate at 37°C for 12 hours), and transfer the activated culture to 400 mL of kanamycin-containing In LB liquid medium of namycin, culture at 37° C. to an OD of 0.6-0.8, add IPTG (final concentration 0.1 mM) and induce culture at 25° C. for 16 hours. Collect the bacteria by centrifugation, resuspend the bacteria in 40mL phosphate buffer (10mM, pH 7.5), and ultrasonically disrupt in an ice-water bath for 15min, and collect the supernatant and precipitate by centrifugation. exists (see figure 2 ), the supernatant was pre-frozen at -20°C, vacuum freeze-dried for 48 hours, and crushed to obtain AtATmut transaminase enzyme powder.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to improved transaminase, an encoding gene and application thereof in preparation of (R)-3-aminobutanol. The improved transaminase is higher than wild transaminase in enzymatic activity. The amino acid sequence of the wild transaminase is shown in SEQ ID No.2 and is rooted in Aspergillus terreus NIH2624. The improved transaminase comprises an amino acid sequence with at least 95% sequence homology as the amino acid sequence shown in the SEQ ID No.2, and the 215th bit corresponding to the amino acid sequence shown in SEQ ID No.2 is a proline residue. The reaction conditions are mild when the improved transaminase is used for preparing (R)-3-aminobutanol, the product is high in chirality purity and yield, the concentration of a substrate reaches up to 50 g/L, and the good industrial application prospect is achieved.

Description

technical field [0001] The invention belongs to the field of biopharmaceuticals, and in particular relates to an improved transaminase, a coding gene and its application in the preparation of (R)-3-aminobutanol. Background technique [0002] (R)-3-Aminobutanol is widely used in chemical reactions and drug synthesis, and can be used as a key intermediate of various chiral drugs. For example, the anti-HIV drug Dolutegravir, developed and manufactured by GlaxoSmithKline (GSK), was approved by the US Food and Drug Administration (FDA) on August 12, 2013. Since its listing, the sales of dolutegravir have shown a rapid development, and the global sales in 2015 reached 9 billion US dollars. [0003] (R)-3-Aminobutanol is a colorless viscous liquid at normal temperature and pressure, with a molecular weight of 89.14, soluble in water, ethanol, ethyl acetate and other solvents, and its structural formula is as follows: [0004] [0005] The synthetic method of (R)-3-aminobutanol...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C12N9/10C12N15/54C12N1/21C12P13/00C12R1/19
CPCC12N9/1096C12P13/001C12Y206/01
Inventor 高新星陆丽英竺伟
Owner SYNCOZYMES SHANGHAI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap